New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 2, 2014
10:00 EDTTXT, SFUN, AMCC, STR, SWX, NFG, MINI, F, NYLD, MVG, EJ, NI, NRG, GM, ALKSOn The Fly: Analyst Initiation Summary
Alkermes (ALKS) initiated with an Outperform at Credit Suisse... E-House (EJ) initiated with a Buy at Brean Capital... Ford (F) initiated with a Neutral at Nomura... General Motors (GM) initiated with a Reduce at Nomura... MAG Silver (MVG) initiated with an Outperform at Scotia Capital... Mobile Mini (MINI) initiated with a Neutral at SunTrust... NRG Energy (NRG) reinstated with an Overweight at Barclays... NRG Yield (NYLD) reinstated with an Equalweight at Barclays... National Fuel (NFG) initiated with a Buy at Jefferies... NiSource (NI) initiated with a Hold at Jefferies... Questar (STR) initiated with a Hold at Jefferies... SouFun (SFUN) initiated with a Buy at Brean Capital Southwest Gas (SWX) initiated with a Hold at Jefferies... Applied Micro Circuits (AMCC) initiated with an Overweight at Evercore... Textron (TXT) resumed with an Overweight at JPMorgan.
News For ALKS;EJ;F;GM;MVG;MINI;NRG;NYLD;NFG;NI;STR;SFUN;SWX;AMCC;TXT From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 25, 2015
12:08 EDTFOptions with increasing volume: EXC POM MDLZ EWJ WBA MW F KMI
Subscribe for More Information
05:36 EDTEJE-House backs FY15 revenue guidance of $1.05B-$1.1B, one estimate $1.07B
05:35 EDTEJE-House reports Q2 EPS 10c, one estimate 5c
Subscribe for More Information
August 24, 2015
19:36 EDTGMGeneral Motors ends two-week strike in Brazil, Reuters says
Subscribe for More Information
17:50 EDTGMGeneral Motors denies 3944 of 4343 ignition switch claims
Subscribe for More Information
16:00 EDTFOptions Update; August 24, 2015
Subscribe for More Information
09:45 EDTGMOn The Fly: Analyst Initiation Summary
Subscribe for More Information
09:18 EDTGMOn The Fly: Pre-market Movers
Subscribe for More Information
08:11 EDTALKSAlkermes delay for Aristada due to administrative issues, says Jefferies
Jefferies said it appears that the FDA's delay in approving Alkermes' Aristada is due to the agency's need for some additional review time. The firm said the fact that the FDA did not choose to issue a CRL letter gives it confidence that Alkermes should receive full approval in a "few weeks" and it maintains its Buy rating and $76 price target on the stock.
08:04 EDTGMGeneral Motors coverage resumed with an Underweight at Morgan Stanley
Subscribe for More Information
06:14 EDTGMGM recalling 59,474 2010 Chevrolet Cobalt vehicles
GM is recalling 59,474 2010 Chevrolet Cobalt vehicles manufactured January 4, 2010, to June 23, 2010. The affected vehicles may be equipped with an improperly routed Side-Impact Sensor wiring harness in the driver side front door. The misrouted wiring harness could cause an electrical short that disables the driver side curtain air bag. A disabled driver side roof-rail air bag will not deploy in the event of a crash necessitating deployment of that air bag, increasing the risk of injury to the driver.
August 23, 2015
18:23 EDTGMGM, Volkswagen slow production at Chinese factories, WSJ says
Auto manufacturers including General Motors (GM) and Volkswagen (VLKAY) appear to be running their Chinese factories at less than maximum capacity for the first time, reports the Wall Street Journal, citing industry data. The numbers suggest that a "bumpier ride" may be in store for multinationals that counted on Chinese demand, said the report. "The situation seems worse than that of 2008," remarked an engineer working at GM's Shanghai plant. Reference Link
August 21, 2015
17:29 EDTNRGPJM releases results for 2018-2019 PJM Interconnection capacity auction
Subscribe for More Information
16:01 EDTALKSAlkermes provides update on FDA review of ARISTADA
Alkermes announced that the U.S. FDA has advised Alkermes that it will not be able to complete its review of the New Drug Application for ARISTADA for the treatment of schizophrenia by the Prescription Drug User Fee Act action date of Aug. 22, 2015. The FDA indicated that this delay was expected to be brief, measured in terms of weeks, but could not confirm specific timing. The FDA also indicated that no additional data or information is required from Alkermes at this time. "We are confident in the ARISTADA program and our NDA submission, and we will work closely with the FDA as they complete their review," said Elliot Ehrich, M.D., Chief Medical Officer of Alkermes. "We look forward to bringing ARISTADA to market as a potential new treatment option to help address the significant unmet medical needs of patients living with schizophrenia."
10:02 EDTAMCCHigh option volume stocks
High option volume stocks: XEO VAR AMCC XPO ROST INTU TFM BTE DXD
06:46 EDTGMGM recalling 5,493 2014-2015 Chevrolet Impala vehicles
Subscribe for More Information
August 20, 2015
10:14 EDTFFord reports Europe sales up 5.3% in July
Subscribe for More Information
10:00 EDTSTROn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:56 EDTSWXSouthwest Gas has reached favorable entry point, says Argus
Subscribe for More Information
05:57 EDTSTRQuestar downgraded to Hold from Buy at Jefferies
Jefferies analyst Christopher Sighinolfi downgraded Questar to Hold with a $22 price target.
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use